Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Patrick D Kirwin Share acquisition in the public market
View:
Post by G1945V on Aug 24, 2022 7:24am

Patrick D Kirwin Share acquisition in the public market

ProMIS Neurosciences, Inc. (TSE:PMN) Director Patrick D. Kirwin Buys 4,000 Shares

 

ProMIS Neurosciences, Inc. (TSE:PMN  Get Rating) Director Patrick D. Kirwin bought 4,000 shares of ProMIS Neurosciences stock in a transaction on Tuesday, August 16th. The stock was acquired at an average cost of C$7.65 per share, with a total value of C$30,600.00. Following the acquisition, the director now owns 41,982 shares in the company, valued at approximately C$321,162.30.

G1945V

Comment by bball67 on Aug 24, 2022 11:36am
Good find. He Bought 4000 shares in the open market during a buying window. Now owns 42,000 shares. Smart guy, check out his legal background. Is independent of Gene and Elliot who bought stock recently. Knows the Boston investors. Figures they should be dosing patients in 5 months (January) knows more about PMN 310 than any of us. Thinks this is a great buying opportunity. Doesn't feel like ...more  
Comment by retiredcop on Aug 24, 2022 12:43pm
Also tells  me that he and other insiders are out of the blackout period where they were encouraged not to't buy or sell on the open market...means we will have a bit of a break for some anticipated signigicant happeneings / news or they feel they have a small window where they can buy or sell before they go into blackout period again... 3rd quarter and summer vacation is just about over ...more  
Comment by M101 on Aug 25, 2022 2:06pm
lol small window, exactly a year since the announced close of the 20 million financing.  No, they're buying because the floor is in and the US bear market looks like it can hold off for a few months while the Europe is sacrificed instead, thus keeping the dollar strong despite historic political incompetence.
Comment by FarmerBetty on Aug 26, 2022 9:14pm
Yes, Promisneuroscineces nothing to do with the markets bears, bulls. There hisotry of repeating  this flag folks. Everything to do with positioning the price for another Boston private placement. Billonaire investors Mike Gordon of Fenway Sports, the Kraft group, Henry McCance, and more. Fools for believing we are in good had hands, being had watch!
Comment by bball67 on Aug 29, 2022 10:23am
Farmer, "Positioning the price" is your charge against the Boston Group in advance of a financing. Tell us all specifically how they are doing this. Your inference is somehow they are pushing the price down. How are they doing that?
Comment by M101 on Aug 29, 2022 12:58pm
Looking forward to it. I noted the Fidelity buyer continued as usual through the last price spike, seems like an accumulation strategy designed to avoid market influence, so maybe Farmer will grace us with an alternative explanation of this too.  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities